Table 4.
CPG | Doyle, C [13] | Rooney, M [14] | Manchon, P [15] | Murray, N [16] | Gradishar, WJ [17] | Harris, SR [18] | Greenlee, H [19] | Komoike, Y [20] | Runowicz, CD [21] | Paluch- Shimon, S [22] | Greenlee, H [23] | Senkus, E [24] |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Treatment Aim | ||||||||||||
Mortality reduction | D ** | |||||||||||
Recurrence risk reduction | C * | A † | ||||||||||
Increase quality of life | B † | A * | ||||||||||
Pain reduction | B ** | A ** | ||||||||||
Fatigue reduction | A ** | B † | C ** | A ** | B ** | |||||||
Lymphedema reduction | B † | D † | B ** | |||||||||
Musculoskeletal changes reduction | B ** | |||||||||||
Increase in range of movement of the shoulder | A ** | |||||||||||
Reduction of body weight alterations | A † | A † | B † | B * | ||||||||
Reduction of bone alterations | D † | D | A † | C † | ||||||||
Reduction of gastrointestinal disorders | ** | * | ||||||||||
Hot flashes reduction | D † | |||||||||||
Neuropathy reduction | C * | |||||||||||
Stress | B * | |||||||||||
Depression | B † | B * | B * | * | ||||||||
Anxiety | B * | B * | * |
* Very recommendable, ** Moderately recommendable, † Controversy.